FI944017A0 - Makrolidien sokerijohdannaiset - Google Patents
Makrolidien sokerijohdannaisetInfo
- Publication number
- FI944017A0 FI944017A0 FI944017A FI944017A FI944017A0 FI 944017 A0 FI944017 A0 FI 944017A0 FI 944017 A FI944017 A FI 944017A FI 944017 A FI944017 A FI 944017A FI 944017 A0 FI944017 A0 FI 944017A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- macrolides
- sugar derivatives
- sec
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84433192A | 1992-03-02 | 1992-03-02 | |
US84433192 | 1992-03-02 | ||
US9300470 | 1993-01-28 | ||
PCT/US1993/000470 WO1993018050A1 (en) | 1992-03-02 | 1993-01-28 | Sugar derivatives of macrolides |
Publications (3)
Publication Number | Publication Date |
---|---|
FI944017A FI944017A (fi) | 1994-09-01 |
FI944017A0 true FI944017A0 (fi) | 1994-09-01 |
FI107535B FI107535B (fi) | 2001-08-31 |
Family
ID=25292419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944017A FI107535B (fi) | 1992-03-02 | 1994-09-01 | Makrolidien sokerijohdannaiset |
Country Status (14)
Country | Link |
---|---|
US (1) | US5747465A (fi) |
EP (1) | EP0629209B1 (fi) |
JP (1) | JP2563080B2 (fi) |
AT (1) | ATE153027T1 (fi) |
AU (1) | AU3586293A (fi) |
CA (1) | CA2131372C (fi) |
DE (1) | DE69310721T2 (fi) |
DK (1) | DK0629209T3 (fi) |
ES (1) | ES2102642T3 (fi) |
FI (1) | FI107535B (fi) |
GR (1) | GR3024048T3 (fi) |
IL (1) | IL104817A0 (fi) |
MX (1) | MX9301060A (fi) |
WO (1) | WO1993018050A1 (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPP584198A0 (en) | 1998-09-14 | 1998-10-08 | Fujisawa Pharmaceutical Co., Ltd. | New use |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
JP2007523896A (ja) | 2004-12-01 | 2007-08-23 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | アスコマイシンの結晶形態とその調製方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1467383A (en) * | 1974-06-12 | 1977-03-16 | Farmaceutici Italia | Daunomycin analogues |
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
AU630866B2 (en) * | 1987-12-09 | 1992-11-12 | Fisons Plc | Macrocyclic compounds |
AU6286690A (en) * | 1989-08-18 | 1991-04-03 | Fisons Plc | Macrocyclic compounds |
IE904050A1 (en) * | 1989-11-13 | 1991-05-22 | Merck & Co Inc | Aminomacrolides and derivatives having immunosuppressive¹activity |
EP0466365A3 (en) * | 1990-07-03 | 1992-04-15 | Merck & Co. Inc. | Novel immunosuppressant fermentation products of a microorganism |
-
1993
- 1993-01-28 JP JP5515662A patent/JP2563080B2/ja not_active Expired - Fee Related
- 1993-01-28 EP EP93904534A patent/EP0629209B1/en not_active Expired - Lifetime
- 1993-01-28 DE DE69310721T patent/DE69310721T2/de not_active Expired - Fee Related
- 1993-01-28 AU AU35862/93A patent/AU3586293A/en not_active Abandoned
- 1993-01-28 DK DK93904534.0T patent/DK0629209T3/da active
- 1993-01-28 AT AT93904534T patent/ATE153027T1/de not_active IP Right Cessation
- 1993-01-28 WO PCT/US1993/000470 patent/WO1993018050A1/en active IP Right Grant
- 1993-01-28 CA CA002131372A patent/CA2131372C/en not_active Expired - Fee Related
- 1993-01-28 US US08/284,504 patent/US5747465A/en not_active Expired - Fee Related
- 1993-01-28 ES ES93904534T patent/ES2102642T3/es not_active Expired - Lifetime
- 1993-02-22 IL IL104817A patent/IL104817A0/xx unknown
- 1993-02-26 MX MX9301060A patent/MX9301060A/es unknown
-
1994
- 1994-09-01 FI FI944017A patent/FI107535B/fi active
-
1997
- 1997-07-09 GR GR970401703T patent/GR3024048T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0629209T3 (da) | 1997-10-13 |
DE69310721T2 (de) | 1997-09-04 |
WO1993018050A1 (en) | 1993-09-16 |
US5747465A (en) | 1998-05-05 |
FI107535B (fi) | 2001-08-31 |
IL104817A0 (en) | 1993-06-10 |
MX9301060A (es) | 1993-09-01 |
CA2131372A1 (en) | 1993-09-16 |
ATE153027T1 (de) | 1997-05-15 |
DE69310721D1 (de) | 1997-06-19 |
FI944017A (fi) | 1994-09-01 |
CA2131372C (en) | 1998-07-14 |
GR3024048T3 (en) | 1997-10-31 |
ES2102642T3 (es) | 1997-08-01 |
JP2563080B2 (ja) | 1996-12-11 |
JPH07500352A (ja) | 1995-01-12 |
AU3586293A (en) | 1993-10-05 |
EP0629209B1 (en) | 1997-05-14 |
EP0629209A1 (en) | 1994-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69622031D1 (de) | INDOLDERIVATE ALS cGMP-PDE INHIBITOREN | |
FR2696176B1 (fr) | Dérivés de pipéridine, leur préparation et leur application en thérapeutique. | |
ZA9610543B (en) | Compounds and compositions for reducing blood glucose and/or inhibiting the activity of CGRP. | |
FR2708608B1 (fr) | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. | |
FR2700167B1 (fr) | Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant. | |
FI972308A (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
FI944014A (fi) | Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina | |
NO20005332L (no) | 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding | |
DK0686155T3 (da) | Xanthinderivater som adenosin A1-receptor-antagonister | |
FI944017A0 (fi) | Makrolidien sokerijohdannaiset | |
DE69612056D1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
DZ1718A1 (fr) | Dérivés de pipéridine, leur préparation et leur application en thérapeutique. | |
ES2016464A6 (es) | Procedimiento para preparar derivados de 2', 5' -oligoadenilato. | |
BG102404A (en) | The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system | |
AU7101994A (en) | Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose | |
DE69012742T2 (de) | Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend. | |
FR2697253B1 (fr) | Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique. | |
FR2699534B1 (fr) | Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique. | |
FR2717814B1 (fr) | Dérivés de 1,2,4-triazolo(4,3-a)pyrazine-4-one, leur préparation et les médicaments les contenant. | |
FR2703355B1 (fr) | Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique. | |
FR2718444B1 (fr) | Dérivés de (3-méthyl-1, 2, 3, 4-tétrahydroquinoléin-8-yl)sulfonyle, leur préparation et leur application en thérapeutique. | |
UA6640A (uk) | Спосіб прогнозування загострення супутнього захворювання при активізації основної патології | |
FR2699174B1 (fr) | Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one, leur préparation et leur application en thérapeutique. | |
FR2718442B1 (fr) | Dérivés de 5-(1H-imidazol-4-yl)-1-oxopentylpipéridine, leur préparation et leur application en thérapeutique. | |
TH14318EX (th) | นิวคลีโอไซด์ที่ใช้ในการรักษาโรค |